GlassScriptPhysician profile
David J Oh
NPI 1750910154
$5,502.06
in general payments reported to CMS, 2019-2025
11 companies · $2,607 in 2025
The $2,607 reported for 2025 was more than what 97% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $176 · 2021: $57.26 · 2024: $2,662 · 2025: $2,607.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,894 · Travel and Lodging: $2,375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,893.69 |
| Travel and Lodging | $2,375.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,697.71 | 2024-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Boston Scientific Corporation | $1,678.33 | 2024-2025 | Wavewriter Alpha Prime 16, Intracept, General - Therapies |
| Saluda Medical Americas, INC. | $279.98 | 2024 | Evoke |
| Nevro Corp. | $275.69 | 2024 | Senza |
| Janssen Pharmaceuticals, INC | $138.36 | 2020-2021 | |
| Abbvie INC. | $121.82 | 2024 | |
| Painteq LLC | $102.66 | 2024 | Painteq |
| Spr Therapeutics, INC | $92.38 | 2024 | Sprint Pns System |
| Astrazeneca Pharmaceuticals LP | $51.58 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $42.98 | 2020-2021 | |
| Globus Medical, INC. | $20.57 | 2025 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Oh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.